SHADE Act
United States · United States Congress · 26 June 2025
The world's political record
Person
![Official portrait of Rep. Matsui, Doris O. [D-CA-7]](https://www.congress.gov/img/member/m001163_200.jpg)
United States · Official source
4,799 records where Rep. Matsui, Doris O. [D-CA-7] is listed as a sponsor, author, or other actor. Search with topics and years
United States · United States Congress · 26 June 2025
United States · United States Congress · 26 June 2025
Mapping America’s Pharmaceutical Supply Act or the MAPS Act This bill requires the Food and Drug Administration (FDA) to continually update its essential medicines list and identify risks and vulnerabilities in the associated supply chains. In 2020, in response to an executive order, the FDA published a list of essential medicines deemed medically necessary to have available at all times. The bill requires the FDA to update and maintain this list to include drugs and ingredients (1) related to responding to public health threats and emergency incidents, (2) that are of greatest priority for providing health care and are at high risk of shortage, and (3) the shortage of which would adversely affect patients with chronic conditions. The FDA must review the list at least every two years and update it as appropriate. Also, the bill requires the FDA to conduct a risk assessment of the supply chains for drugs and ingredients on the list and annually report its findings to Congress. The assessment must include information about key manufacturing materials, drugs with primarily foreign or single suppliers, manufacturing capacity, relevant public health and national security risks, and risk mitigation strategies. Additionally, the Department of Health and Human Services (HHS) must map and monitor relevant supply chains to identify vulnerabilities and provide an annual status report to Congress. HHS must facilitate the secure exchange of information among agencies regarding locations and quantities of production and relevant regulatory actions.
United States · United States Congress · 26 June 2025
United States · United States Congress · 26 June 2025
United States · United States Congress · 26 June 2025
United States · United States Congress · 26 June 2025
United States · United States Congress · 25 June 2025
United States · United States Congress · 24 June 2025
Women's Health Protection Act of 2025 This bill prohibits governmental restrictions on the provision of, and access to, abortion services. Before fetal viability, governments may not restrict providers from using particular abortion procedures or drugs, offering abortion services via telemedicine, or immediately providing abortion services if delaying risks the patient's health. Furthermore, governments may not require providers to perform unnecessary medical procedures, provide medically inaccurate information, or comply with credentialing or other conditions that do not apply to providers who offer medically comparable services to abortions. Additionally, governments may not require patients to make medically unnecessary in-person visits before receiving abortion services or disclose their reasons for obtaining services. After fetal viability, governments may not restrict providers from performing abortions when necessary to protect a patient's life and health. The same provisions that apply to abortions before viability also apply to necessary abortions after viability. Additionally, states may authorize post-viability abortions in circumstances beyond those that the bill considers necessary. Further, the bill recognizes an individual's right to interstate travel, including for abortion services. The bill also prohibits governments from implementing measures that are similar to those restricted by the bill or that otherwise target and impede access to abortion services, unless the measure significantly advances the safety of abortion services or health of patients and cannot be achieved through less restrictive means. The Department of Justice, individuals, or providers may sue states or government officials to enforce this bill, regardless of certain immunity that would otherwise apply.
United States · United States Congress · 24 June 2025
United States · United States Congress · 24 June 2025
United States · United States Congress · 24 June 2025
United States · United States Congress · 24 June 2025
United States · United States Congress · 23 June 2025
United States · United States Congress · 23 June 2025
This concurrent resolution directs the President to remove U.S. Armed Forces from hostilities against Iran unless explicitly authorized by a declaration of war or a congressional authorization for use of military force against Iran. Elements of the U.S. Armed Forces needed to defend the United States, an ally, or a partner from imminent attack are not covered by this requirement provided the President complies with a specified provision of the War Powers Resolution. (The provision generally requires the President to remove U.S. Armed Forces from hostilities no more than 60 days after the President notifies or is required to notify Congress of such involvement, unless Congress authorizes such use. For more information on the War Powers Resolution, see CRS In Focus 13134 .)
United States · United States Congress · 23 June 2025
United States · United States Congress · 17 June 2025
This concurrent resolution directs the President to terminate the use of U.S. Armed Forces from hostilities against Iran or any part of the Iranian government or military unless a declaration of war or authorization to use military force for such purpose has been enacted. The resolution specifies that it shall not be construed to prevent the United States from defending itself from imminent attack.
United States · United States Congress · 12 June 2025
United States · United States Congress · 12 June 2025
United States · United States Congress · 12 June 2025
United States · United States Congress · 11 June 2025
United States · United States Congress · 11 June 2025
United States · United States Congress · 11 June 2025
United States · United States Congress · 10 June 2025
Bipartisan Background Checks Act of 2025 This bill establishes new background check requirements for firearm transfers between private parties (i.e., unlicensed individuals). Specifically, it prohibits a firearm transfer between private parties unless a licensed gun dealer, manufacturer, or importer first takes possession of the firearm to conduct a background check. The prohibition does not apply to certain firearm transfers or exchanges, such as a gift between spouses.
United States · United States Congress · 10 June 2025
United States · United States Congress · 6 June 2025
United States · United States Congress · 6 June 2025
United States · United States Congress · 6 June 2025
United States · United States Congress · 5 June 2025
United States · United States Congress · 4 June 2025
United States · United States Congress · 4 June 2025
This resolution expresses the House of Representatives' grave concern with (1) the humanitarian crisis and acute suffering of Palestinian civilians in Gaza, and (2) the suffering of the hostages and hostage families. The resolution also calls on the White House, the Department of State, and other relevant federal agencies to use all available diplomatic tools to bring about the release of the hostages, the disbursement of food and humanitarian aid to Palestinian civilians, and a durable end to the Gaza conflict.
United States · United States Congress · 4 June 2025
Equal Access to Justice for Victims of Gun Violence Act of 2025 This bill removes limitations on the civil liability of gun manufacturers and the disclosure of gun trace data in civil actions. Specifically, the bill repeals the Protection of Lawful Commerce in Arms Act, which prohibits civil actions against a firearm or ammunition manufacturer, seller, importer, dealer, or trade association for damages resulting from the criminal or unlawful misuse of a firearm. Additionally, the bill states that firearms trace data maintained by the Bureau of Alcohol, Tobacco, Firearms and Explosives is not immune from legal process. Such data is subject to discovery; is admissible as evidence; and may be used, relied on, or disclosed in a civil action or administrative proceeding.
United States · United States Congress · 4 June 2025
United States · United States Congress · 3 June 2025
United States · United States Congress · 2 June 2025
United States · United States Congress · 29 May 2025
Menstrual Equity For All Act of 2025 This bill expands access to menstrual products (e.g., tampons) in certain locations and for particular groups, such as in schools and for low-income individuals, through federal programs and requirements. It also prohibits state or local sales taxes for these products. The bill expands access to menstrual products through federal programs by requiring Medicaid to cover such products, establishing grants within the Temporary Assistance for Needy Families (TANF) program to provide benefits to ensure access to such products, authorizing the Emergency Food and Shelter Program to provide menstrual products to homeless individuals, and increasing Social Services Block Grant funding to provide such products to low-income individuals. Also, the bill sets out requirements to make free menstrual products available in federal and state correctional facilities (including Department of Homeland Security detention facilities) and restrooms in federal buildings that are open to the public. Further, the bill (1) establishes grants to provide free menstrual products to students at institutions of higher education, and (2) permits elementary and secondary schools to use certain grant funds to provide menstrual products to students. In addition, the bill requires employers with at least 100 employees to provide free menstrual products for employees. Finally, the bill prohibits states and local governments from taxing retail sales of menstrual products.
United States · United States Congress · 29 May 2025
United States · United States Congress · 29 May 2025
United States · United States Congress · 23 May 2025
United States · United States Congress · 23 May 2025
United States · United States Congress · 21 May 2025
United States · United States Congress · 21 May 2025
United States · United States Congress · 21 May 2025
This resolution declares mental health a national priority and supports the designation of Mental Health Awareness Month.
United States · United States Congress · 20 May 2025
Improving Seniors' Timely Access to Care Act of 2025 This bill establishes several requirements and standards relating to prior authorization processes under Medicare Advantage (MA) plans. Specifically, MA plans must (1) establish an electronic prior authorization program that meets specified standards; (2) annually submit to the CMS for publication specified prior authorization information, including the percentage of requests approved and the average response time; and (3) meet other standards, as set by the Centers for Medicare & Medicaid Services (CMS), relating to the quality and timeliness of prior authorization determinations. The CMS and the Office of the National Coordinator for Health Information Technology must publish on the CMS' website a report that analyzes the information received from MA plans, the feasibility of implementing real-time decision making with respect to prior authorization requests, and the impact of decisions that are made using artificial intelligence on patient access.
United States · United States Congress · 19 May 2025
United States · United States Congress · 15 May 2025
Stronger Communities through Better Transit Act This bill requires the Department of Transportation (DOT) to establish a grant program to support operating projects for public transportation and related service improvements, particularly in underserved communities and areas of persistent poverty. Specifically, the bill requires DOT to allocate funding under the program for urbanized areas, states, and Indian tribes that are recipients of funds under either the Federal Transit Administration's (FTA's) Urbanized Area Formula Funding program or Formula Grants for Rural Areas program. Eligible recipients may use funding for operating costs associated with projects that improve public transportation service for transit-dependent populations and support increased transit ridership (e.g., service expansion, information technology enhancements, and workforce development). DOT must apportion the funding so that recipients receive funds that are proportional to their share of operating costs. The bill also provides for an increased federal cost share for operating assistance for projects or programs carried out in areas of persistent poverty or underserved communities. DOT must set up a multimodal access measurement interface for public agencies to aid transit agencies in determining and reporting on access to jobs and essential services. A grant recipient must (1) report specific information to the FTA for inclusion in the National Transit Database, and (2) survey transit riders and non-riding residents regarding transit service improvements. Further, the bill expands the purposes of the public transportation programs to include supporting public transportation's role in combating climate change through growing/retaining transit ridership.
United States · United States Congress · 13 May 2025
United States · United States Congress · 13 May 2025
United States · United States Congress · 13 May 2025
United States · United States Congress · 8 May 2025
United States · United States Congress · 7 May 2025